Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Verweij

Showing results (41-50 of 655) with videos related to

Pageof 66
Sort By:
Hematology (Amsterdam, Netherlands)|July 14, 2016
Moving the Frontiers of Cancer Chemotherapy for Solid Tumors by Changing the Scope of Drug DevelopmentM J De Jonge, J Verweij
Current Opinion in Infectious Diseases|August 5, 2010
Newer diagnostic approaches to intestinal protozoaLisette van Lieshout, Jaco J Verweij
European Journal of Cancer (Oxford, England : 1990)|May 8, 2007
Cytotoxic therapy for the elderly with metastatic breast cancer: a review on safety, pharmacokinetics and efficacyP Hamberg, J Verweij, C Seynaeve
European Journal of Cancer (Oxford, England : 1990)|August 15, 2002
Dosing strategies for anticancer drugs: the good, the bad and body-surface areaA Felici, J Verweij, A Sparreboom
Parasitology|August 24, 2011
Intestinal parasitic infections in an industrialized country; a new focus on children with better DNA-based diagnosticsJaco J Verweij, Lisette van Lieshout
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1994
Paclitaxel (Taxol) and docetaxel (Taxotere): not simply two of a kindJ Verweij, M Clavel, B Chevalier
Clinical Microbiology Reviews|April 4, 2014
Molecular testing for clinical diagnosis and epidemiological investigations of intestinal parasitic infectionsJaco J Verweij, C Rune Stensvold
Cancer Chemotherapy and Biological Response Modifiers|May 9, 2000
MitomycinsJ Verweij, A Sparreboom, K Nooter
European Journal of Cancer (Oxford, England : 1990)|August 10, 2000
Achievements and future of chemotherapyJ Verweij, M J de Jonge
Nederlands Tijdschrift Voor Geneeskunde|December 18, 1993
[Strongyloides stercoralis: an insidious oddity]A M Polderman, J J Verweij
Pageof 66

Showing results (41-50 of 655) with videos related to

Sort By:
Pageof 66
Hematology (Amsterdam, Netherlands)|July 14, 2016
Moving the Frontiers of Cancer Chemotherapy for Solid Tumors by Changing the Scope of Drug DevelopmentM J De Jonge, J Verweij
Current Opinion in Infectious Diseases|August 5, 2010
Newer diagnostic approaches to intestinal protozoaLisette van Lieshout, Jaco J Verweij
European Journal of Cancer (Oxford, England : 1990)|May 8, 2007
Cytotoxic therapy for the elderly with metastatic breast cancer: a review on safety, pharmacokinetics and efficacyP Hamberg, J Verweij, C Seynaeve
European Journal of Cancer (Oxford, England : 1990)|August 15, 2002
Dosing strategies for anticancer drugs: the good, the bad and body-surface areaA Felici, J Verweij, A Sparreboom
Parasitology|August 24, 2011
Intestinal parasitic infections in an industrialized country; a new focus on children with better DNA-based diagnosticsJaco J Verweij, Lisette van Lieshout
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1994
Paclitaxel (Taxol) and docetaxel (Taxotere): not simply two of a kindJ Verweij, M Clavel, B Chevalier
Clinical Microbiology Reviews|April 4, 2014
Molecular testing for clinical diagnosis and epidemiological investigations of intestinal parasitic infectionsJaco J Verweij, C Rune Stensvold
Cancer Chemotherapy and Biological Response Modifiers|May 9, 2000
MitomycinsJ Verweij, A Sparreboom, K Nooter
European Journal of Cancer (Oxford, England : 1990)|August 10, 2000
Achievements and future of chemotherapyJ Verweij, M J de Jonge
Nederlands Tijdschrift Voor Geneeskunde|December 18, 1993
[Strongyloides stercoralis: an insidious oddity]A M Polderman, J J Verweij
Pageof 66